`
`LUMIFY® Clinical Information
`
`Back to ~
`
`for Consume, s
`
`L LJ MlF Y
`
`<O~CNUS nUI\U t'n o~o, s
`
`~ '/J W.
`
`II>
`
`FREQUENTLY ASKED QUESTIONS
`
`+ Woa o triol conducted between LUMIFY ond currently ovoiloble
`OTC redneaa reliever eye dropa?
`
`+ Whot % of benzolkonium chloride (BAK) preaervotive ia in
`LUMIFY?
`
`+ Were there ony incidencea of ollergic reoction to low doae
`brimonidine tortrote?
`
`+ Whot typea of potienta/cpecioltiea would LUMIFY be good for?
`
`+ How will LUMIFY offect pupil dilotion?
`
`+ Whot ia the difference between LUM I FY ond current OTC redneaa
`relievera?
`
`+ Con LUM I FY be uaed to counteroct rebound redneaa from other
`gloucomo treotmenta?
`
`+ Woa there on introoculor preaaure (IOP) lowering effect?
`
`+ Doea LUM I FY couae rebound redneaa ond tochyphyloxia aimilor to
`other OTC redneaa relievera?
`
`+ How long doea LUMIFY loat?
`
`+ How quickly doea LUM I FY work?
`
`https://www.lumifydrops.com/professional/clinical-information
`
`1/4
`
`Eye Therapies Exhibit 2110, 1 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`7/12/22, 8 57 PM
`
`LUM I FY® Clinical Information
`
`Back to ~
`
`fo r Consume, s
`
`L LJ MlF Y
`
`<O~CN U S nUI\U t 'n o~o, s
`
`~ '/J W.
`
`II>
`
`+ How did LUM I FY obtein FDA epprovel?
`
`LUMIFY is so effective at reducing redness, your patients can see the difference almost immediately.*
`
`FAST ACTING AND LONG LASTING EFFICACY1
`
`Reported significant
`improvement
`in just one minutet
`
`Maintained significant
`redness reduction
`at eight hou,.t
`
`•
`•
`
`-simulation to reflect average clinical trial results.
`teased on patient reported findings from Phase 3.
`
`Representative of mean
`pre-instillation score: 1.8
`
`Representative of mean
`5 minute post-instillation: 0.5
`
`LOW RISK FOR TACHYPHYLAXIS OR REBOUND HYPEREMIA 1
`
`~ Phase Ill efficacy study2:
`
`41
`
`During Treatment
`Consistent efficacy showed no
`evidence of tachyp hylaxis
`
`~H t l ll 'Ht Ht
`
`Post Treatment
`Return to baseline showed no
`evidence of rebo und hyperemia
`
`Treatment Group:
`I Placebo
`I Low Dose Brimonid ine
`
`Days
`
`p<0.0001·
`
`Overall, cix clinicel studies were conducted in over 600 patients to evaluate safety and efficacy,
`with no evidence of ellergic reection• reported.
`
`1 McL.-urin E Cavet ME GomH PJ Ciolini JB. Brimonidin e o p hthalmic solution 0 .025% for reduction of oculu t•dnHs. Optom Vis Sci. 2018 in preu On•
`teport•d UH o f t • bound hyperem a in Pha u
`Ill Safety Study_ 2Pha u Ill was a double •blind•d ra ndomized p lac•bo contro lled study. n•60.
`
`https://www.lumifydrops.com/professional/clinical-information
`
`2/4
`
`Eye Therapies Exhibit 2110, 2 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`7/12/22, 8 57 PM
`
`LUMIFY® Clinical Information
`
`Back to ~
`
`for Consume, s
`
`L LJ MfF Y
`
`<O~C N U S nUI\U t 'n o~o, s
`
`~ '/JW. II>
`
`LUM I FY is the only OTC
`redness reliever t hat primarily
`constricts the venule.
`
`WATCH THE VIDEO >
`
`DRUG FACTS
`
`Direc:tiona
`
`Adulte end children 5 yeere of age end over:
`
`• instill 1 drop in the affected eye(s) every 6-8 hours
`• do not use more than 4 times daily
`• remove contact lenses before use
`• wait at least 10 minutes before re-inserting contact
`lenses after use
`• if using other ophthalmic products while using this
`product, wait at least 5 minutes between each
`product
`• to avoid contamination, do not toud, tip of
`container to any surface
`• replace cap after each use
`
`Children under 5 yeere of age: consult a doctor
`
`See full Drug Facts
`
`Join our professional mailing list
`
`SUBSCRIBE
`
`https://www.lumifydrops.com/professional/clinical-information
`
`3/4
`
`Eye Therapies Exhibit 2110, 3 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`7/12/22, 8 57 PM
`
`LUMIFY® Clinical Information
`
`Back to ~
`
`for Consume, s
`
`L LJ MlF Y
`
`<O~C N US nUI\U t'n o~o, s
`
`~ '/JW. Ii"
`
`https://www.lumifydrops.com/professional/clinical-information
`
`4/4
`
`Eye Therapies Exhibit 2110, 4 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
